Europe Blood Group Typing Market

Europe Blood Group Typing Market Size & Growth (2022 to 2027):

The Europe Blood Group Typing Market size is anticipated to grow at a 10.21 % CAGR from 2022 to 2027. This regional market was worth USD 0.63 billion in 2022 and is expected to grow USD 1.02 billion by 2027.

DRIVERS

The increasing amount of blood donations and transfusions has benefitted the blood group market. Different non-profit organizations, government agencies and other agencies are highlighting the importance of blood donation and transfusion and raising awareness through various campaigns. The increase in donated blood has increased the demand for blood groups so that the donor can know what type of blood they have. For example, according to the WHO, blood donations increased from 2015 to 2019 with 7.9 million donations of blood from voluntary unpaid donors between 2015 and 2019. The increase in the number of blood donations and transfusions has thus contributed to the growth of the blood typing market.

Technological advancements, such as automated technologies for blood group, are gaining ground in the blood group market. Leading companies in the market are focused on introducing a new type of testing based on innovative techniques that deliver results in reduced response time, with greater precision and efficiency. These factors will drive market growth rate in the upcoming years.

RESTRAINTS

Lack of awareness and a shortage of trained and skilled professionals can lead to deceptive transfusions, leading to lower sales of reagents for blood banks and ultimately hampering the growth of the blood group market.

OPPORTUNITIES

Leading companies in the market are focused on introducing new types of testing based on innovative techniques that deliver results in reduced response time, with increased accuracy and efficiency, thus providing good opportunities for the market.

CHALLENGES

Unfortunately, the COVID-19 epidemic has led to a drastic drop in voluntary blood donation around the world, due to fears over the safety standards of the equipment used and the imposition of closures in most countries. Health systems in most European countries have started to become alert as existing blood supplies have started to deplete. These factor play a challenge for the market growth rate.

This research report on the Europe Blood Group Typing Market has been segmented and sub-segmented into the following categories:

By Product: 

• Consumables 
  • Antisera Reagents
  • Red Blood Cell Reagents
  • Anti-Human Globulin Reagents
  • Blood Bank Saline
• Instrument
• Services.

By Test Type: 

• ABO
• Antigen
• Antibody Screening
• Cross Matching
• HLA

By Technique: 

• Assay
• PCR
• Microarray
• Massively Parallel Sequencing

By End User: 

• Hospitals
• Clinical Laboratories
• Blood Banks

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

REGIONAL ANALYSIS

The UK holds major market share in APAC blood group typing market. This is mainly due to the high rate of adoption of advanced blood typing tests and methods in the region. In addition, Hospitals operating in the region receive adequate regulatory support, which has created an enabling environment for innovation in the health sector. France is expected to register an impressive CAGR due to the growing demand for safe blood transfusion techniques, while the Sweden will show tremendous growth due to the increasing prevalence of chronic diseases such as anemia.

The UK's National Health Service (NHS) reported in 2020 that voluntary donations had fallen by 16%. Such sudden drops in blood donation are likely to have unfathomable effects on patients with conditions such as thalassemia and hemophilia, which require regular blood transfusions. As the efficiency of blood typing mechanisms dependent mostly on blood donation, a decrease in blood bank storage will have a negative impact on the growth of the blood typing market. Following this decrease due to covid-19 pandemic, the market is expected to increase in market growth rate.

KEY MARKET PLAYERS:

A few of the promising companies operating in the European blood group typing market profiled in this report are Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.